Why is aTyr Pharma Stock (ATYR) Down 7% Today?
Shares in biopharmaceutical firm aTyr Pharma ($ATYR) dropped 7% today despite hopes that a trial for its lung disease drug efzofitimod was back on ...
Atyr Pharma Inc (ATYR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 65,263.7 | $1,557,975 | +427% | 0% |
| 2. | Kalehua Capital Management Tai-Li Chang | 44,704.175 | $1,067,178 | 0.61% | |
| 3. | Citadel Investment Group Ken Griffin | 31,051.675 | $741,265 | +2522% | 0% |
| 4. | Millennium Management Israel Englander | 16,401.275 | $391,531 | -61% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 9,203 | $220,872 | +167% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.50 | 100,000 | $49,630.00 | 779,143 | 2026-05-27 | Filing | |
| $0.94 | 317,999 | $299,364.26 | 1,413,023 | 2025-10-09 | Filing | |
| $0.90 | 682,001 | $612,436.90 | 1,095,024 | 2025-10-08 | Filing | |
| $4.00 | 3,750 | $15,000.00 | 9,750 | 2025-03-17 | Filing | |
| $1.93 | 52,300 | $101,038.37 | 413,023 | 2024-07-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 3,745 | $3,655.12 | 153,553 | 2026-02-04 | Filing | |
| $0.98 | 1,558 | $1,520.61 | 37,296 | 2026-02-04 | Filing | |
| $0.98 | 1,118 | $1,091.28 | 33,124 | 2026-02-04 | Filing | |
| $3.78 | 1,254 | $4,740.12 | 31,763 | 2025-02-04 | Filing | |
| $3.78 | 899 | $3,398.22 | 26,555 | 2025-02-04 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,300 | $15,756 | 0% | |
| 2. | 527.3 | $5,385 | 0% | |
| 3. | 50 | $606 | 0% | |
| 4. | 49.475 | $600 | 0% | |
| 5. | 8.95 | $108 | 0% |
News See All
Lead Therapy Trial Fuels aTyr Pharma's (ATYR) Promising Upside, Leerink Stays Bullish
aTyr Pharma Inc. (NASDAQ:ATYR) is one of the best multibagger stocks to invest in right now. On August 22, Leerink Partners’ Faisal Khurshid reiterated a Buy rating on aTyr Pharma Inc.
15 Best Multibagger Stocks to Invest in Right Now
In this article, we will examine the 15 Best Multibagger Stocks to Invest in Right Now.
Top 10 Stocks Under $10 That Could Triple
On Friday, September 5, the three major averages closed in the red following a weaker-than-expected US jobs report, which caused concerns about a slowing economy.
ATyr Pharma Rated as Overweight at Cantor Fitzgerald on Efzofitimod Expectations
aTyr Pharma, Inc. (NASDAQ:ATYR) is one of the top multibagger penny stocks to buy, according to analysts. On August 4, analysts at Cantor Fitzgerald reiterated an ‘Overweight’ rating on the stock.
13 Best Multibagger Penny Stocks to Buy According to Analysts
In this article, we will take a detailed look at the 13 Best Multibagger Penny Stocks to Buy According to Analysts.
13 Best Multibagger Stocks to Invest in Now
In this article, we identify the 13 Best Multibagger Stocks to invest in now.
10 Low Risk High Reward Stocks Set to Triple by 2030
In this article, we will discuss 10 Low Risk High Reward Stocks Set to Triple by 2030.
10 Hot Biotech Stocks Under $5
In this article, we will look at 10 Hot Biotech Stocks Under $5.
aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Call Transcript
aTyr Pharma, Inc. (NASDAQ:ATYR) Q4 2024 Earnings Call Transcript March 13, 2025aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23.
Hedge Fund Resource Center